Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SASSAN KAVEH

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1851385447
CMS profile
219606
Location
LAS VEGAS, NV

General Payments · PY2018–2024

$22,768.41

  • Reported across 441 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,251.88

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,251.88 33

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lumenis BE inc $1,032.16 1
Acerta Pharma LLC $595.01 14
Novo Nordisk AS $167.46 5
Boehringer Ingelheim Pharmaceuticals, Inc. $137.17 2
Amgen Inc. $121.85 1
Paratek Pharmaceuticals, Inc. $48.76 3
PFIZER INC. $47.91 2
Medtronic, Inc. $26.71 1
Bayer HealthCare Pharmaceuticals Inc. $24.00 1
Abbott Laboratories $19.17 1
DEXCOM, INC. $17.17 1
ABBVIE INC. $14.51 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,368.01 69
PY2019 $3,043.77 93
PY2020 $846.01 41
PY2021 $1,996.97 75
PY2022 $2,102.05 80
PY2023 $10,159.72 50
PY2024 $2,251.88 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $19.17 07/11/2024 Food and Beverage Undisputed 01/23/2026 1125303381 CMS
ABBVIE INC. $14.51 01/25/2024 Food and Beverage Undisputed 01/23/2026 1104043272 CMS
Amgen Inc. $121.85 06/26/2024 Food and Beverage Undisputed 01/23/2026 1117594981 CMS
AstraZeneca Pharmaceuticals LP $23.67 01/08/2024 Food and Beverage Undisputed 01/23/2026 1105672479 CMS
AstraZeneca Pharmaceuticals LP $121.81 02/27/2024 Food and Beverage Undisputed 01/23/2026 1105515495 CMS
AstraZeneca Pharmaceuticals LP $20.74 03/22/2024 Food and Beverage Undisputed 01/23/2026 1105305006 CMS
AstraZeneca Pharmaceuticals LP $116.27 03/27/2024 Food and Beverage Undisputed 01/23/2026 1105450821 CMS
AstraZeneca Pharmaceuticals LP $20.64 05/20/2024 Food and Beverage Undisputed 01/23/2026 1104743445 CMS
AstraZeneca Pharmaceuticals LP $31.95 06/03/2024 Food and Beverage Undisputed 01/23/2026 1104224703 CMS
AstraZeneca Pharmaceuticals LP $19.81 06/04/2024 Food and Beverage Undisputed 01/23/2026 1104501334 CMS
AstraZeneca Pharmaceuticals LP $116.27 06/12/2024 Food and Beverage Undisputed 01/23/2026 1104278315 CMS
AstraZeneca Pharmaceuticals LP $25.22 07/23/2024 Food and Beverage Undisputed 01/23/2026 1105876641 CMS
AstraZeneca Pharmaceuticals LP $19.20 08/05/2024 Food and Beverage Undisputed 01/23/2026 1104722173 CMS
AstraZeneca Pharmaceuticals LP $17.94 09/04/2024 Food and Beverage Undisputed 01/23/2026 1105561122 CMS
AstraZeneca Pharmaceuticals LP $16.96 10/08/2024 Food and Beverage Undisputed 01/23/2026 1104616284 CMS
AstraZeneca Pharmaceuticals LP $15.49 11/11/2024 Food and Beverage Undisputed 01/23/2026 1104255189 CMS
AstraZeneca Pharmaceuticals LP $29.04 12/16/2024 Food and Beverage Undisputed 01/23/2026 1105309606 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.00 02/29/2024 Food and Beverage Undisputed 01/23/2026 1086204069 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.52 03/18/2024 Food and Beverage Undisputed 01/23/2026 1118184863 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $120.65 04/09/2024 Food and Beverage Undisputed 01/23/2026 1118184867 CMS
Dexcom, Inc. $17.17 12/01/2024 Food and Beverage Undisputed 01/23/2026 1153334641 CMS
Lumenis BE inc $1,032.16 11/08/2024 Food and Beverage Undisputed 01/23/2026 1082155464 CMS
Medtronic, Inc. $26.71 05/17/2024 Food and Beverage Undisputed 01/23/2026 1119515441 CMS
Novo Nordisk Inc $12.03 02/20/2024 Food and Beverage Undisputed 01/23/2026 1096733372 CMS
Novo Nordisk Inc $9.65 03/20/2024 Food and Beverage Undisputed 01/23/2026 1096603407 CMS
Novo Nordisk Inc $14.95 06/04/2024 Food and Beverage Undisputed 01/23/2026 1096833996 CMS
Novo Nordisk Inc $119.26 09/05/2024 Food and Beverage Undisputed 01/23/2026 1097636048 CMS
Novo Nordisk Inc $11.57 10/04/2024 Food and Beverage Undisputed 01/23/2026 1097253547 CMS
Paratek Pharmaceuticals, Inc. $17.73 04/16/2024 Food and Beverage Undisputed 01/23/2026 1113905847 CMS
Paratek Pharmaceuticals, Inc. $17.13 11/26/2024 Food and Beverage Undisputed 01/23/2026 1113905849 CMS
Paratek Pharmaceuticals, Inc. $13.90 12/20/2024 Food and Beverage Undisputed 01/23/2026 1113905851 CMS
PFIZER INC. $33.61 05/07/2024 Food and Beverage Undisputed 01/23/2026 1131555949 CMS
PFIZER INC. $14.30 07/30/2024 Food and Beverage Undisputed 01/23/2026 1131220258 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.